Correction to:: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)
Files
Publication date
2024-02-01
Authors
Buis, David
van der Vaart, Thomas
Prins, J M
van der Meer, J T M
Bonten, Marc
Sieswerda, Elske
Van Werkhoven, Cornelis H.
Sigaloff, K C E
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc
Abstract
To our regret we realized that the following error was present in multivariable analyses, neither cefuroxime nor ceftriaxone was the original published version of this article: In the Abstract, associated with increased duration of bacteraemia compared Results section: “In multivariable analyses, neither ceftriaxone with flucloxacillin (HR 1.08, 95% CI 0.73–1.60 and HR 1.22, 95% nor cefuroxime was associated with increased duration of CI 0.88–1.71)”. bacteraemia compared with flucloxacillin (HR 1.08, 95% CI The overall conclusions of the study remain unaltered. 0.73–1.60 and HR 1.22, 95% CI 0.88–1.71)” should read “In We apologize for the inconvenience.
Keywords
Published Erratum
Citation
Buis, D T P, van der Vaart, T W, Prins, J M, van der Meer, J T M, Bonten, M J M, Sieswerda, E, van Werkhoven, C H & Sigaloff, K C E 2024, 'Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study (Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkad057)', The Journal of antimicrobial chemotherapy, vol. 79, no. 2, dkad385, pp. 476. https://doi.org/10.1093/jac/dkad385